FIELD: medicine; oncology.
SUBSTANCE: group of inventions is intended for the treatment of cancer. The pharmaceutical combination for the treatment of breast cancer comprises (1) compound A1 of the following formula or a pharmaceutically acceptable salt thereof, and (2) a fulvestrant or a pharmaceutically acceptable salt thereof. Also the following is provided: the use of a pharmaceutical combination comprising (1) compound A1 of formula A1 below, or a pharmaceutically acceptable salt thereof, and (2) a fulvestrant, or a pharmaceutically acceptable salt thereof, for the treatment of breast cancer.
EFFECT: use of the group of inventions makes it possible to increase the effectiveness of breast cancer treatment due to a synergistic effect.
17 cl, 31 dwg, 5 tbl, 7 ex
| Title |
Year |
Author |
Number |
| COMBINATION THERAPY FOR TREATMENT OF CANCER |
2014 |
- Chen Yan
- Khuan Sichzhun
- Kim Sunkiu
|
RU2680714C2 |
| PHARMACEUTICAL COMBINATION COMPRISING INHIBITOR PHOSPHATYLENOSITOL 3-KINASES AND AROMATASE INHIBITOR |
2013 |
- Goldbrunner Mikhael
- Khuan Sichzhun
|
RU2651023C2 |
| METHOD OF TREATING AND PREVENTING TUMOUR WHICH IS AMENABLE TO ENDOCRINE THERAPY, USING COMBINED USE OF FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR AND ENDOCRINE THERAPY |
2019 |
- Hirai, Hiroshi
- Miura, Akihiro
- Sootome, Hiroshi
|
RU2825636C2 |
| ANTI-TUMOR COMPOSITIONS CONTAINING RAPAMICINE DERIVATIVE AND AROMATASE INHIBITOR |
2004 |
- Sherman Mehtt'Ju L.
- Gibbons Dzhehjms Dzh. Ml.
- Berger Mark
- Magvajr Robert T.
- Fridman Robert
|
RU2355399C2 |
| METHOD AND SET FOR TREATING AND PREVENTING MALIGNANT TUMOURS OF FEMALE REPRODUCTIVE SYSTEM USING 9-OXOACRIDINE-10-ACETIC ACID, AND/OR SALT THEREOF AND/OR ESTER THEREOF |
2007 |
- Surkov Kirill Gennadievich
|
RU2363466C2 |
| METHODS OF TREATING AR+ BREAST CANCER |
2017 |
- Khatterslej, Gari
- Saekh, Dzhamal
- Yuj, Tsziyan
- Miller, Kris
- Bikhani, Tiru
|
RU2769527C2 |
| COUMARIN DERIVATIVE FOR TREATMENT OR PREVENTION OF CELL PROLIFERATION DISORDERS |
2017 |
|
RU2760006C1 |
| COMBINATION INCLUDING CYCLIN-DEPENDENT KINASE 4 INHIBITOR OR CYCLIN-DEPENDENT KINASE 6 INHIBITOR (CDK4/6) AND mTOR INHIBITOR FOR TREATING CANCER |
2011 |
- Borland Mariya
- Brejn Kristofer Tomas
- Doshi Shivang
- Kim Sunkiu
- Ma Tszyango
- Merti Dzhosh
- Chzhan Khun
|
RU2589696C2 |
| METHODS FOR TREATING PANCREATIC CANCER |
2017 |
- Bekker Petrus
- Miao Shichang
- Charo Israel
- Schall Tom
|
RU2768479C2 |
| PI-3 KINASE DOSAGE REGIME |
2013 |
- Khiravat Samit
- Massachezi Kristian
|
RU2630975C2 |
